These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 30946043)
21. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Larkin GL; Beautrais AL Int J Neuropsychopharmacol; 2011 Sep; 14(8):1127-31. PubMed ID: 21557878 [TBL] [Abstract][Full Text] [Related]
22. Is Ketamine the Future Clozapine for Depression? A Case Series and Literature Review on Maintenance Ketamine in Treatment-resistant Depression With Suicidal Behavior. Chan LF; Eu CL; Soh SY; Maniam T; Shahidii Kadir Z; Chong BTW; Loo JL; Sharip S; Wong VCW; Loo TH; Ng YP; Kahn DA J Psychiatr Pract; 2018 Jul; 24(4):279-291. PubMed ID: 30427812 [TBL] [Abstract][Full Text] [Related]
23. Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder. Zheng W; Zhou YL; Liu WJ; Wang CY; Zhan YN; Li HQ; Chen LJ; Li MD; Ning YP J Affect Disord; 2019 Mar; 246():241-247. PubMed ID: 30590286 [TBL] [Abstract][Full Text] [Related]
24. A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action. Naughton M; Clarke G; O'Leary OF; Cryan JF; Dinan TG J Affect Disord; 2014 Mar; 156():24-35. PubMed ID: 24388038 [TBL] [Abstract][Full Text] [Related]
25. Nitrous Oxide Reduced Suicidal Ideation in Treatment-Resistant Major Depression in Exploratory Analysis. de Leon VC; Kumar A; Nagele P; Palanca BJ; Gott B; Janski A; Zorumski CF; Conway CR J Clin Psychiatry; 2023 Aug; 84(5):. PubMed ID: 37585253 [No Abstract] [Full Text] [Related]
26. Neurocognitive effects of six ketamine infusions and the association with antidepressant response in patients with unipolar and bipolar depression. Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y J Psychopharmacol; 2018 Oct; 32(10):1118-1126. PubMed ID: 30260273 [TBL] [Abstract][Full Text] [Related]
27. Ketamine and esketamine for suicidal ideation: Recent progress and practical issues. Bartoli F; Wlkinson ST Aust N Z J Psychiatry; 2020 Feb; 54(2):206-207. PubMed ID: 31830803 [No Abstract] [Full Text] [Related]
28. Ketamine for suicidal ideation treatment: Available evidence remains convincing. Bartoli F; Crocamo C; Carrà G Neurosci Biobehav Rev; 2019 Apr; 99():1-2. PubMed ID: 30682382 [No Abstract] [Full Text] [Related]
29. Intravenous ketamine infusion for a patient with treatment-resistant major depression: a 10-month follow-up. Kwon JH; Sim WS; Hong JP; Song IS; Lee JY J Clin Pharm Ther; 2018 Aug; 43(4):581-583. PubMed ID: 29372569 [TBL] [Abstract][Full Text] [Related]
30. Single, Repeated, and Maintenance Ketamine Infusions for Treatment-Resistant Depression: A Randomized Controlled Trial. Phillips JL; Norris S; Talbot J; Birmingham M; Hatchard T; Ortiz A; Owoeye O; Batten LA; Blier P Am J Psychiatry; 2019 May; 176(5):401-409. PubMed ID: 30922101 [TBL] [Abstract][Full Text] [Related]
31. Use of ketamine for acute suicidal ideation in a patient with chronic pain on prescribed cannabinoids. Bigman D; Kunaparaju S; Bobrin B BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29133582 [TBL] [Abstract][Full Text] [Related]
32. Ketamine Use for Suicidal Ideation in the General Hospital: Case Report and Short Review. Vulser H; Vulser C; Rieutord M; Passeron A; Lefebvre D; Baup E; Seigneurie AS; Thauvin I; Limosin F; Lemogne C J Psychiatr Pract; 2018 Jan; 24(1):56-59. PubMed ID: 29320385 [TBL] [Abstract][Full Text] [Related]
33. Ketamine followed by memantine for the treatment of major depression. Kollmar R; Markovic K; Thürauf N; Schmitt H; Kornhuber J Aust N Z J Psychiatry; 2008 Feb; 42(2):170. PubMed ID: 18197514 [No Abstract] [Full Text] [Related]
35. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study. Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208 [TBL] [Abstract][Full Text] [Related]
36. Ketamine: Quo Vadis? Nemeroff CB Am J Psychiatry; 2018 Apr; 175(4):297-299. PubMed ID: 29606064 [No Abstract] [Full Text] [Related]
37. Serial infusions of low-dose ketamine for major depression. Rasmussen KG; Lineberry TW; Galardy CW; Kung S; Lapid MI; Palmer BA; Ritter MJ; Schak KM; Sola CL; Hanson AJ; Frye MA J Psychopharmacol; 2013 May; 27(5):444-50. PubMed ID: 23428794 [TBL] [Abstract][Full Text] [Related]
38. Research suggests new drug targets for depression. Pilot studies of ketamine intrigue scientists, but risks of this anesthetic limit its clinical use. Harv Ment Health Lett; 2010 Nov; 27(5):6. PubMed ID: 21218614 [No Abstract] [Full Text] [Related]
39. Sublingual Ketamine for Rapid Relief of Suicidal Ideation. Grande LA Prim Care Companion CNS Disord; 2017 Mar; 19(2):. PubMed ID: 28282103 [No Abstract] [Full Text] [Related]
40. How does ketamine elicit a rapid antidepressant response? Kavalali ET; Monteggia LM Curr Opin Pharmacol; 2015 Feb; 20():35-9. PubMed ID: 25462290 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]